3.15: Blood tests 3.15.1: Estimation of the concentration of haemoglobin in donor blood The haemoglobin (Hb) concentration should be determined each time a potential donor pre…
Minutes of the JPAC meeting 06-11-2023.pdf (204KB)
Your privacy - how cookies are used by UKBTS UKBTS uses small amounts of data stored on your computer called 'cookies' to collect information about how visitors use the website. You can…
7.7: Components suitable for use in Intrauterine Transfusion, Neonates and Infants under 1 year General requirements Unless they are subjected to a validated pathogen i…
7.6: Granulocyte Components Granulocyte components are manufactured from whole blood-derived buffy coats and are not leucodepleted. Specifications
7.5: Plasma Components Plasma components are manufactured from whole blood or apheresis collections. These components a rapidly frozen to retain labile clotting factors. All plasma compo…
7.4: Platelet Components Platelet components are manufactured from pooling whole blood-derived buffy coats or directly from apheresis collections. They are suspended in plasma with or wi…
7.3: Red Cell Components Red cell components are manufactured from whole blood or apheresis donations and suspended in additive solution and/or plasma. All red cell components are leucoc…
7.2: Whole Blood Components Whole blood components are collected from UK donors as described in Chapter 5. These components undergo primary processing to separate the blood constituents …